Edge Conversion Launches Custom AI Systems to Supercharge Sales and Scale Growth for Small Businesses 
Capital Markets Malaysia Expands Simplified ESG Disclosure Guide with a GHG Emission Calculator for SMEs 
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets 
EUDR Solution From Source Intelligence Simplifies Deforestation Due Diligence 
Spacely AI Secures US $1 Million Seed Round to Supercharge Generative AI Design for Architects Worldwide Eledon Pharmaceuticals Announces Update on Development Strategy for AT-1501 in Renal Transplantation
IRVINE, Calif., April 26, 2021 (GLOBE NEWSWIRE) — Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a…
AGTC Announces Departure of Chief Scientific Officer
GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
Aptose to Report First Quarter 2021 Financial Results and Hold Conference Call on Tuesday, May 4, 2021
SAN DIEGO and TORONTO, April 26, 2021 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO;…
Inventiva to participate at the 7th Annual Truist Securities Life Sciences Summit
Daix (France), April 26, 2021 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical…
ZIVO Bioscience Announces US Patent Office Notice of Allowance for Administration of Proprietary Algal Biomass to Support Immune Health
KEEGO HARBOR, Mich., April 26, 2021 (GLOBE NEWSWIRE) — ZIVO Bioscience, Inc. (OTCMKTS:ZIVO) a biotech/agtech…
OSE Immunotherapeutics and Veloxis Pharmaceuticals Enter Into Global License Agreement to Develop, Manufacture, and Commercialize FR104, a CD28 Antagonist, in the Organ Transplantation Market
Agreement expands Veloxis’ product portfolio and the continued commitment to improving the lives of transplant…
Delisting of Kiadis will be effective on 25 May 2021
This is a joint press release by Sanofi Foreign Participations B.V. (the “Offeror”), Sanofi (“Sanofi”)…
UPDATE – Advaxis Announces Achievement of Second Milestone Under ADXS-HER2 Licensing Agreement with OS Therapies
Non-dilutive capital will support advancement of ADXS-HOT neoantigen program PRINCETON, N.J., April 26, 2021 (GLOBE…
22nd Century Delivers 3.6 Million Variable Nicotine Content Research Cigarettes for Independent Scientific Studies
To Date, 22nd Century Has Provided More Than 31 Million Variable Nicotine Content Research Cigarettes for…
G1 Therapeutics Announces Publication of Pooled Results from Pivotal Clinical Program of COSELA™ (trilaciclib) in Clinical Lung Cancer
– Pivotal Program Evaluated the Effects of Administering COSELA Prior to Chemotherapy on Clinically Relevant…
Multi-center Study Demonstrates Significant Reductions in Postoperative Pain and Opioid Use Following Peripheral Nerve Stimulation Treatment
Findings Published as Congress Demands Review of Medicare Coverage for Non-opioid Treatments CLEVELAND, April 26,…
Biosplice Publishes Successful Clinical Trial in Knee Osteoarthritis
Biosplice’s Phase 2b trial for lorecivivint hits primary endpoint in osteoarthritis pain SAN DIEGO, April…
Vallon Pharmaceuticals to Participate at the 4th Annual Neuroscience Innovation Forum
David Baker, President and CEO of Vallon to participate in the virtual Advances in Neuropsychiatry…
INmune Bio, Inc. Announces Participation in Fireside Chat at the B Riley Neurosciences Conference
LA JOLLA, Calif, April 26, 2021 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the…
Turning Point Therapeutics to Host First Quarter 2021 Conference Call
SAN DIEGO, April 26, 2021 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a…
One World Pharma Announces First Sale of Cuttings in Colombia
LAS VEGAS, NV, April 26, 2021 (GLOBE NEWSWIRE) — via NewMediaWire ‒ One World Pharma…
Better Choice Announces Appointment of Former Blue Buffalo Founding Shareholder, Gil Fronzaglia, to the Board of Directors
NEW YORK, April 26, 2021 (GLOBE NEWSWIRE) — Better Choice Company (OTCQX: BTTR) (“Better Choice”),…
Cassava Sciences Invited by the NIH to Participate in Sachs 4th Annual Neuroscience Innovation Forum
AUSTIN, Texas, April 26, 2021 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a clinical-stage…
Vertex and CRISPR Therapeutics Announce Priority Medicines (PRIME) Designation Granted by the European Medicines Agency to CTX001™ for Transfusion-Dependent Beta Thalassemia
BOSTON and CAMBRIDGE, Mass. and ZUG, Switzerland, April 26, 2021 (GLOBE NEWSWIRE) — Vertex Pharmaceuticals…
Antares Pharma Appoints Dr. Peter Richardson as Executive Vice President, Research and Development and Chief Medical Officer
EWING, N.J., April 26, 2021 (GLOBE NEWSWIRE) — Antares Pharma, Inc. (NASDAQ: ATRS) (“the Company”),…